Objective
T cells are key constituents of our immune system. Two types of T cells are conserved evolutionary and across species: αβ and γδ T cells. While αβ T cells have been intensively studied during the last decades, our knowledge on the development and activation of γδ T cells is still limited. Recently, γδ T cells have become increasingly attractive for immunotherapy of cancer due to efficient killing of tumour cells independently of major histocompatibility complex (MHC) antigen presentation. The proposed project will elucidate how T cell receptor (TCR) signalling is initiated in γδ T cells; and how it contributes to the developmental programming of γδ T cell subsets strongly implicated in cancer immunity.
In a pioneer experiment, cellular barcoding and single-cell RNA sequencing will be combined with recent γδ T cell subset markers to gain unprecedented insight into precursor-product and lineage relationships in γδ T cell development; and towards identifying its key molecular determinants. Moreover, TCRγδ signalling will be addressed in thymic subset development at protein and mRNA level by cutting-edge flow-cytometry based techniques. Results of both experimental lines will be integrated to elucidate TCRγδ signalling characteristics and their impact on subset development and functional programming of γδ T cells. The acquired knowledge will enhance our understanding of γδ T cells and allow for their manipulation and fine-tuning in clinical applications.
The supervisor’s outstanding expertise in γδ T cells and their role in cancer, in synergy with the researcher’s deep experience in antigen receptor signalling, form the optimal basis for this challenging project. Moreover, the researcher strongly benefits by increasing her research technology and transferable skills in a new, stimulating scientific environment within a privileged EU network. This will enable her to move to the next career stage and to further contribute to the innovative research landscape in Europe.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins
- natural sciences biological sciences genetics RNA transcriptomes
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine immunology immunotherapy
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF-EF-ST - Standard EF
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2016
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1649 028 Lisboa
Portugal
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.